Cognitive-motor Training in Parkinson Disease
NCT06588439, Not applicable, Recruiting, National Yang Ming Chiao Tung University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Cognitive-motor Training in Parkinson Disease | ClinicalTrials.gov |
| NCT number | NCT06588439 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | National Yang Ming Chiao Tung University | ClinicalTrials.gov |
| Conditions | Parkinson Disease | ClinicalTrials.gov |
| Interventions | Cognitive-motor training, Conventional physiotherapy | ClinicalTrials.gov |
| First posted | 2024-09-19 | ClinicalTrials.gov |
| Last updated | 2025-06-12 | ClinicalTrials.gov |
Registered outcomes 17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Gait variability | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure the coefficient of variation (CV). The mean and standard deviation will be used to calculate the coefficient of variation (CV). CV = standard deviation / mean \* 100% | ClinicalTrials.gov |
| Primary | Gait speed | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure gait speed | ClinicalTrials.gov |
| Primary | Step length | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure step length | ClinicalTrials.gov |
| Primary | Step width | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure step width | ClinicalTrials.gov |
| Primary | Single support time | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure single support time | ClinicalTrials.gov |
| Primary | Double support time | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Using GAITRite system to measure double support time | ClinicalTrials.gov |
| Primary | Frontal Assessment Battery | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | The score ranged from 0 to 18. Higher scores show better executive function. | ClinicalTrials.gov |
| Primary | Stroop color and word test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Record numbers of corrected color words which the subject responds within 45 sec. | ClinicalTrials.gov |
| Primary | Digit span test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Digit span test contain forward and backward part. Scores of forward digit span ranges from 0 to 16. Score of backward digit span ranges from 0 to 14. Higher scores indicate better executive function. | ClinicalTrials.gov |
| Primary | Event-related potential - N2 | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Measure event-related potential through electroencephalography under single-task and dual-task paradigm. | ClinicalTrials.gov |
| Primary | Event-related potential - P300 | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Measure event-related potential through electroencephalography under single-task and dual-task paradigm. | ClinicalTrials.gov |
| Primary | Go/Nogo test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Behavioral test during measuring electroencephalography. | ClinicalTrials.gov |
| Primary | Trail making test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Trail making test contain part A and part B. Faster completing the test indicates better executive function. | ClinicalTrials.gov |
| Secondary | Mini-Balance Evaluation Systems Test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Mini-Balance Evaluation Systems Test scores range from 0 to 28. Higher scores indicate better balance ability. | ClinicalTrials.gov |
| Secondary | Montreal Cognitive Assessment | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Montreal Cognitive Assessment ranges from 0 to 30. Higher scores reflect better cognitive performances. | ClinicalTrials.gov |
| Secondary | Timed up and go test | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Record time of performing timed up and go test | ClinicalTrials.gov |
| Secondary | Parkinson Disease Questionnaire | Before and after 8 weeks of intervention, as well as 4 weeks after intervention | Parkinson Disease Questionnaire assess quality of life in people with Parkinson disease. Lower scores reflect higher quality of life. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Primary outcome | ConductCognition |
| Go/No-Go Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)